AlphaYou
Overview
Smart money at a glance
Filings to Oct 12, 2026No insider open-market trades in 90 days (SEC Form 4). Congress: no trades disclosed in 180 days.
- Company insidersSEC Form 4, last 90 days
- $0No open-market trades
- CongressSTOCK Act, last 180 days
- NoneNo trades disclosed
- Big fundsSEC 13F, latest quarter
- NoneNo large changes
- Federal contractsUSAspending.gov, last 12 months
- No awardsNone on record
Market overview
Fundamentals Oct 12- Open
- $2.42
- 52-wk high
- $76.50
- High
- $2.49
- 52-wk low
- $2.05
- Low
- $2.30
- Prev close
- $2.59
- Mkt cap
- $4.2M
- Volume
- 302.8K
- Beta
- 1.80
- P/S
- 1.5x
- P/B
- 0.5x
- Profit margin
- +0.0%
- Op margin
- +19652.0%
- ROE
- -459.5%
What do analysts expect?
No analyst estimates.
Questions about VBIO filings
Are insiders buying or selling Valion Bio Inc (VBIO) stock?
Neither. Valion Bio Inc (VBIO) insiders filed no open-market purchases or sales in the 90 days to Oct 12, 2026, according to SEC Form 4 filings.
Which members of Congress have traded VBIO recently?
None. No member of Congress disclosed a VBIO trade with a trade date in the last 180 days, according to House and Senate STOCK Act filings.
How current is this VBIO smart-money data?
This summary uses filings available on Oct 12, 2026. Insiders must report trades to the SEC within 2 business days, members of Congress have up to 45 days to disclose a trade, and funds file 13F holdings up to 45 days after each quarter ends, so the latest moves may not be public yet.
Smart money
1 fund holds a position.
How top traders are positioned
No tracked top-trader positions in VBIO right now.
Live Hyperliquid positioning - not every stock is covered
Earnings
Results versus expectations
No reported figure for the latest quarter.
Company release linked above, where available
Previous reports
All values in USD| Period ending | Reported | EPS / estimate | EPS surprise | Revenue / estimate | Rev. surprise |
|---|---|---|---|---|---|
| Mar 31, 2026 | May 15, 2026 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2025 | Nov 17, 2025 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2025 | Aug 15, 2025 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2025 | May 15, 2025 | Unavailable | - | Unavailable | Unavailable |
| Dec 31, 2024 | Mar 24, 2025 | Unavailable | - | Unavailable | Unavailable |
| Sep 30, 2024 | Nov 15, 2024 | Unavailable | - | Unavailable | Unavailable |
| Jun 30, 2024 | Aug 15, 2024 | Unavailable | - | Unavailable | Unavailable |
| Mar 31, 2024 | May 16, 2024 | Unavailable | - | Unavailable | Unavailable |
EPS uses Yahoo Finance where available, then Alpha Vantage or verified release comparisons. Revenue uses company releases and saved estimates.
Reports Nov 13, 2026, in 32 days
Financials
Is the business strong?
This company is running thin margins.
- Net margin
- 0.0%
- Market cap
- $4M
Valuation
- P/S1.52
- P/B0.52
Quality
- Operating margin19652.0%
- ROE-459.5%
- ROA-57.1%
Growth
- Beta1.80
Technicals
Price structure
This stock is under pressure.
Trend
Under pressure
15 / 100
RSI 14
20D volatility
52-week range
20D support
20D resistance
Returns
Price vs moving averages
Volume pace